ReviewFrontiers in immunology2024

Photonanozyme-Kras-ribosome combination treatment of non-small cell lung cancer after COVID-19.

Qiaoyan Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.